Cargando…

Evaluation of liver fibrosis in patients with Wilson’s disease

OBJECTIVES: Staging of fibrosis in chronic liver disease is important for prognosis and treatment planning. Liver biopsy is the gold standard in fibrosis assessment; however, new methods for fibrosis and stiffness measurement exist which have not been evaluated in patients with Wilson’s disease. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Przybyłkowski, Adam, Szeligowska, Jowita, Januszewicz, Magdalena, Raszeja-Wyszomirska, Joanna, Szczepankiewicz, Benedykt, Nehring, Piotr, Górnicka, Barbara, Litwin, Tomasz, Członkowska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2020
Materias:	Original Articles: Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565503/ https://www.ncbi.nlm.nih.gov/pubmed/32433421 http://dx.doi.org/10.1097/MEG.0000000000001754

Ejemplares similares

Elastography of the Liver in Wilson’s Disease
por: Nehring, Piotr, et al.
Publicado: (2023)

Liver transplantation as a treatment for Wilson’s disease with neurological presentation: a systematic literature review
por: Litwin, Tomasz, et al.
Publicado: (2022)

Copper Deficiency as Wilson’s Disease Overtreatment: A Systematic Review
por: Litwin, Tomasz, et al.
Publicado: (2023)

Early neurological deterioration in Wilson’s disease: a systematic literature review and meta-analysis
por: Antos, Agnieszka, et al.
Publicado: (2023)

The Maternal and Fetal Outcomes of Pregnancy in Wilson’s Disease: A Systematic Literature Review and Meta-Analysis
por: Litwin, Tomasz, et al.
Publicado: (2022)

Intestinal expression of metal transporters in Wilson’s disease
por: Przybyłkowski, Adam, et al.
Publicado: (2013)

Loss of hepatic Mboat7 leads to liver fibrosis
por: Thangapandi, Veera Raghavan, et al.
Publicado: (2021)

Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
por: Grażyna, Gromadzka, et al.
Publicado: (2013)

Erratum to: Treatment with d-penicillamine or zinc sulphate affects copper metabolism and improves but not normalizes antioxidant capacity parameters in Wilson disease
por: Gromadzka, Grażyna, et al.
Publicado: (2014)

Concordance rates of Wilson’s disease phenotype among siblings
por: Chabik, Grzegorz, et al.
Publicado: (2013)

Iron metabolism is disturbed and anti-copper treatment improves but does not normalize iron metabolism in Wilson’s disease
por: Gromadzka, Grażyna, et al.
Publicado: (2021)

Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson’s disease
por: Ziemssen, Tjalf, et al.
Publicado: (2022)

Evaluation of vitamin B(6) supplementation in Wilson’s disease patients treated with D-penicillamine
por: Mbala, Justin, et al.
Publicado: (2023)

Erratum to: Concordance rates of Wilson’s disease phenotype among siblings
por: Chabik, Grzegorz, et al.
Publicado: (2014)

Osteoporosis in primary biliary cirrhosis of the liver
por: Raszeja-Wyszomirska, Joanna, et al.
Publicado: (2014)

Validation of Novel Fibrosis Index (NFI) for assessment of liver fibrosis: comparison with transient elastography (FibroScan)
por: Hussain, Azhar, et al.
Publicado: (2019)

Persistence with treatment for Wilson disease: a retrospective study
por: Masełbas, Wojciech, et al.
Publicado: (2019)

Sodium(+)/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
por: Salhab, Ahmad, et al.
Publicado: (2022)

Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cells
por: Dai, Zhen, et al.
Publicado: (2020)

Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
por: Angelini, Giulia, et al.
Publicado: (2023)

Diagnosis of Wilson Disease and Its Phenotypes by Using Artificial Intelligence
por: Medici, Valentina, et al.
Publicado: (2021)

Social and demographic characteristics of a Polish cohort with Wilson disease and the impact of treatment persistence
por: Maselbas, Wojciech, et al.
Publicado: (2019)

Less liver fibrosis marker increment in overweight chronic hepatitis B patients observed by age-adjusted Fibrosis-4 Index
por: Liu, Ta-Wei, et al.
Publicado: (2020)

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
por: Hardy, Timothy, et al.
Publicado: (2017)

Cardiac assessment in Wilson’s disease patients based on electrocardiography and echocardiography examination
por: Buksińska-Lisik, Małgorzata, et al.
Publicado: (2017)

The sunflower cataract in Wilson’s disease: pathognomonic sign or rare finding?
por: Langwińska-Wośko, Ewa, et al.
Publicado: (2015)

Bis‐choline Tetrathiomolybdate as Old Drug in a New Design for Wilson’s Disease: Good for Brain and Liver?
por: Stremmel, Wolfgang
Publicado: (2018)

Autoantibodies in Wilson disease: Impact on clinical course
por: Antczak‐Kowalska, Magdalena, et al.
Publicado: (2022)

Optical coherence tomography and electrophysiology of retinal and visual pathways in Wilson’s disease
por: Langwińska-Wośko, Ewa, et al.
Publicado: (2015)

Sleep disturbances in newly diagnosed treatment-naïve patients with Wilson’s disease
por: Jernajczyk, Wojciech, et al.
Publicado: (2022)

Psychiatric manifestations in Wilson’s disease: possibilities and difficulties for treatment
por: Litwin, Tomasz, et al.
Publicado: (2018)

Characteristics of a newly diagnosed Polish cohort of patients with neurological manifestations of Wilson disease evaluated with the Unified Wilson’s Disease Rating Scale
por: Członkowska, Anna, et al.
Publicado: (2018)

Prevalence of and risk factors for non-alcoholic fatty liver disease (NAFLD) and fibrosis among young adults in Egypt
por: Tomah, Shaheen, et al.
Publicado: (2021)

FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2
por: Rao, Jianhua, et al.
Publicado: (2022)

Influence of BDNF polymorphisms on Wilson’s disease susceptibility and clinical course
por: Mirowska-Guzel, Dagmara, et al.
Publicado: (2013)

Brain volume is related to neurological impairment and to copper overload in Wilson’s disease
por: Smolinski, Lukasz, et al.
Publicado: (2019)

Optical coherence tomography as a marker of neurodegeneration in patients with Wilson’s disease
por: Langwińska-Wośko, Ewa, et al.
Publicado: (2017)

The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa
por: Lemoine, Maud, et al.
Publicado: (2016)

Is Psoriasis Treatment a Risk Factor for Inflammatory Bowel Disease?
por: Nehring, Piotr, et al.
Publicado: (2020)

Blink reflex in newly diagnosed and treated patients with Wilson’s disease
por: Bembenek, Jan P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0hdrf5m41p4okul4535o4fd305